Sean F. Scanlan's Insider Trades & SAST Disclosures
Sean F. Scanlan's most recent trade in Treace Medical Concepts Inc was a trade of 50,000 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sean F. Scanlan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 17 Mar 2025 | 50,000 | 414,081 | - | 1.1 | 52,500 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 50,000 | 16,875 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 7.97 per share. | 17 Mar 2025 | 50,000 | 364,081 | - | 8.0 | 398,460 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2025 | 1,396 | 364,081 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2025 | 401 | 365,477 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 140,625 | 365,878 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Jan 2025 | 4,821 | 225,253 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2024 | 33,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 12 Sep 2024 | 33,750 | 250,074 | - | 0.1 | 3,281 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 120,900 | 216,324 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2024 | 1,396 | 95,424 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2024 | 389 | 96,820 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | F. Scanlan Sean | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 73,200 | 73,200 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 65,025 | 97,209 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 25.44 per share. | 16 May 2023 | 25,000 | 32,395 | - | 25.4 | 635,978 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 25,000 | 33,750 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 16 May 2023 | 25,000 | 57,395 | - | 0.1 | 2,500 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 51,950 | 51,950 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 22,925 | 32,395 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 24.41 per share. | 09 Mar 2023 | 505 | 9,470 | - | 24.4 | 12,327 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 15 Feb 2023 | 25,000 | 34,975 | - | 0.1 | 2,500 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 25,000 | 58,750 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 21.69 per share. | 15 Feb 2023 | 25,000 | 9,975 | - | 21.7 | 542,235 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 12 Jan 2023 | 25,000 | 34,975 | - | 0.1 | 2,500 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 25.57 per share. | 12 Jan 2023 | 25,000 | 9,975 | - | 25.6 | 639,308 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2023 | 25,000 | 83,750 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 24.27 per share. | 14 Nov 2022 | 25,000 | 9,975 | - | 24.3 | 606,680 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2022 | 25,000 | 108,750 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 14 Nov 2022 | 25,000 | 34,975 | - | 0.1 | 2,500 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 23,000 | 23,000 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 3,400 | 9,975 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 50,650 | 50,650 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 6,575 | 6,575 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.82 per share. | 02 Mar 2022 | 25,000 | 0 | - | 20.8 | 520,550 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 02 Mar 2022 | 25,000 | 25,000 | - | 1.1 | 26,250 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 25,000 | 124,149 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 08 Feb 2022 | 21,127 | 21,127 | - | 1.0 | 22,183 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 21,127 | 153,022 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 08 Feb 2022 | 21,127 | 0 | - | 20.0 | 422,889 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 3,873 | 149,149 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 08 Feb 2022 | 3,873 | 0 | - | 20.2 | 78,082 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 08 Feb 2022 | 3,873 | 3,873 | - | 1.1 | 4,067 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 10 Jan 2022 | 38,862 | 0 | - | 20.2 | 783,532 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 10 Jan 2022 | 30,631 | 38,862 | - | 1.6 | 48,091 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 30,631 | 36,244 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 10 Jan 2022 | 8,838 | 0 | - | 20.1 | 177,846 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 8,231 | 46,993 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 10 Jan 2022 | 8,231 | 8,231 | - | 1.6 | 12,923 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 10 Jan 2022 | 6,414 | 8,838 | - | 1.1 | 6,735 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 6,414 | 174,149 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 10 Jan 2022 | 2,424 | 2,424 | - | 1.6 | 3,806 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 2,424 | 33,820 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 03 Jan 2022 | 1,000 | 1,000 | - | 1.6 | 1,570 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 03 Jan 2022 | 1,000 | 0 | - | 20.0 | 20,021 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 1,000 | 56,524 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 03 Jan 2022 | 800 | 0 | - | 20.0 | 16,018 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 03 Jan 2022 | 800 | 800 | - | 1.6 | 1,256 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 800 | 55,224 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 03 Jan 2022 | 500 | 0 | - | 20 | 10,000 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 03 Jan 2022 | 500 | 500 | - | 1.6 | 785 | Common Stock |
| Treace Medical Concepts Inc | Sean F. Scanlan | SVP, Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 500 | 56,024 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Sean F. Scanlan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 66,875 | 66,875 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges